Close Menu

NEW YORK (360Dx) – Magnolia Medical Technologies is alleging Kurin is infringing four patents covering Maganolia's blood collection device.

Last week, Magnolia amended a complaint filed in the US District Court for the District of Delaware to allege that Kurin is infringing four Magnolia patents — US Patent No. 9,855,001, US Patent No. 10,028,689, US Patent No. 10,039,483, and US Patent No. 10,220,139 — covering its blood collection platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
23
Sponsored by
Qiagen: Nov 16, 2014

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.